63857-00-1

Basic information

• Product Name: 3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE
• Synonyms: N-[(2-CHLORO-1-PHENYLIMINOMETHYL-1-CYCLOHEXENE-3-YLIDENE)METHYL]ANILINE HYDROCHLORIDE;N-[(3-(ANILINOMETHYLENE)-2-CHLORO-1-CYCLOHEXEN-1-YL)METHYLENE]ANILINE MONOHYDROCHLORIDE;N-((3-[ANILINOMETHYLIDENE]-2-CHLORO-1-CYCLOHEXEN-1-YL)METHYLIDENE)ANILINE HYDROCHLORIDE;3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE;BENZENAMINE, N-[[2-CHLORO-3-[(PHENYLAMINO)METHYLENE]-1-CYCLOHEXEN-1-YL]METHYLENE]-, MONOHYDROCHLORIDE;N-((3-(anilinomethylene)-2-chloro-1-cyclo-hexen-1;N-2-chloro-3-(phenylamino)methylene-1-cyclohexen-1-ylmethylene-Benzenaminemonohydrochloride;N-((3-(ANILINOMETHYLENE)-2-CHLORO-1-CYC&
• CAS NO: 63857-00-1
• Molecular Formula: C₂₀H₁₉ClN₂*ClH
• Molecular Weight: 359.29
• EINECS: 1533716-785-6
• Product Categories: A;Stains and Dyes;Stains&Dyes, A to
• Mol File: 63857-00-1.mol
• Article Data: 19

Chemical Properties

• Melting Point: 224 °C (dec.)(lit.)
• Boiling Point: 473.9 °C at 760 mmHg
• Flash Point: 240.4 °C
• Appearance: /
• Vapor Pressure: 2.24E-09mmHg at 25°C
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE(63857-00-1)
• EPA Substance Registry System: 3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE(63857-00-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 63857-00-1(Hazardous Substances Data)

Usage

Description

3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE is a chemical compound that is primarily utilized as a research chemical. It is characterized by its unique molecular structure and properties, which make it valuable for various scientific investigations and applications.

Uses

Used in Research Applications:
3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE is used as a research chemical for its potential applications in the field of chemistry and related disciplines. Its unique properties and reactivity contribute to the advancement of scientific knowledge and the development of new materials and compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE is used as an intermediate or building block in the synthesis of various pharmaceutical compounds. Its specific chemical properties make it a valuable component in the development of new drugs and medications.
Used in Chemical Synthesis:
3-CHLORO-2,4-TRIMETHYLENENGLUTACONDIANIL HYDROCHLORIDE is also used in chemical synthesis as a key component in the production of other chemicals and materials. Its versatility and reactivity enable it to be employed in a wide range of chemical reactions, leading to the creation of various products with diverse applications.

InChI:InChI=1/C20H19ClN2.ClH/c21-20-16(14-22-18-10-3-1-4-11-18)8-7-9-17(20)15-23-19-12-5-2-6-13-19;/h1-6,10-15,22H,7-9H2;1H/b16-14+,23-15+;

Upstream product

• 108-94-1 cyclohexanone 
• 68-12-2 N,N-dimethyl-formamide 
• 62-53-3 aniline 
• 64-17-5 ethanol 
• 83710-73-0 1-chloro-2,6-diformylcyclohexene 
• 90945-00-9 2-Chlor-3-dimethylamino-methylen-cyclohex-1-en-carbaldehyd 

Downstream Products

• 97605-56-6 3-((E)-2-{2-Chloro-3-[2-[4-phenyl-4H-benzo[f]quinolin-(3Z)-ylidene]-eth-(E)-ylidene]-cyclohex-1-enyl}-vinyl)-4-phenyl-benzo[f]quinolinium; iodide 
• 97605-59-9 3-((E)-2-{2-Chloro-3-[2-[4-(4-methoxy-phenyl)-4H-benzo[f]quinolin-(3Z)-ylidene]-eth-(E)-ylidene]-cyclohex-1-enyl}-vinyl)-4-(4-methoxy-phenyl)-benzo[f]quinolinium; iodide 
• 1107604-88-5 C₇H₇O₃S^(1-)*C₃₆H₄₆ClN₄O₄S₂⁽¹⁺⁾ 
• 134127-48-3 2-[2-[2-chloro-3-[2-(1,3-dihydro-1,1,3-trimethyl-2H-benzo[e]-indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-1,1,3-trimethyl-1H-benzo[e]indolium p-toluenesulfonate 
• 162411-29-2 IR-739 
• 56289-67-9 2-((E)-2-((E)-2-chloro-3-(2-((E)-1,3,3-trimethylindolin-2-ylidene)ethylidene)cyclohex-1-en-1-yl)vinyl)-1,3,3-trimethyl-3H-indol-1-ium iodide 
• 65303-15-3 2-[2-[2-chloro-3-[2-(3-ethyl-3H-benzothiazol-2-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-3-ethylbenzothiazol-3-ium iodide 

Relevant articles and documents

Heptamethine indocyanine dye as well as preparation method and application thereof

The invention provides a heptamethine indocyanine dye as well as a preparation method and an application thereof, and belongs to the technical field of fine chemical engineering. The heptamethine indocyanine dye provided by the invention has a structure a

Ligand taking indocyanine green derivative as carrier as well as preparation method and application of ligand

The invention discloses a ligand taking an indocyanine green derivative as a carrier as well as a preparation method and application of the ligand. When the ligand is chelated with paramagnetic metal ions, an NIR/MRI multi-mode contrast agent is obtained, when the ligand is chelated with radioactive metal ions, an NIR/PET multi-mode contrast agent is obtained, and the obtained contrast agents can be used for diagnosis of various tumors, especially liver cancer. Meanwhile, the contrast agents are good in water solubility and low in toxicity, mutual verification of multiple contrast modes is achieved, diagnosis information is enriched, diagnosis precision is improved, and a feasible novel contrast agent is provided for early diagnosis of tumors clinically.

NIR/MRI bimodal contrast agent, and preparation method and application thereof

The invention discloses a near infrared imaging and nuclear magnetic resonance imaging (NIR)/MRI bimodal contrast agent, and a preparation method and application thereof. The NIR/MRI bimodal contrast agent is obtained by taking an optimized indocyanine green derivative as a carrier and connecting an MRI signal molecule. The contrast agent can be used for near-infrared imaging and also has an MRI imaging capability; and meanwhile, water solubility is good, toxicity is low, near-infrared and MRI images verify each other, diagnosis information is enriched, and the contrast agent has the potential of becoming a novel tumor contrast agent.